Erythrocyte and Platelet Phospholipid Fatty Acids as Markers of Advanced Non-Small Cell Lung Cancer: Comparison with Serum Levels of Sialic Acid, TPS and Cyfra 21-1

REFERENCES

• Yogeeswaran G. Cell surface glycolipids and glycoproteins in malignant transformation. Adv Cancer Res 1983; 38: 289–350
   PubMed Web of Science ®Google Scholar
• Schauer R. Sialic acid as antigenic determinants of complex carbohydrates. Adv Exp Med Biol 1988; 228: 47–72
   PubMedGoogle Scholar
• Narayanan S. Sialic acid as a tumor marker. Ann Clin Lab Sci 1994; 24(4)376–384
   PubMed Web of Science ®Google Scholar
• Patel P. S., Baxi B. R., Balar D. B. Significance of serum sialoglycoproteins in patients with lung cancer. Neoplasma 1989; 36(1)53–59
   PubMed Web of Science ®Google Scholar
• Stringou E., Chondros K., Kouvaris J., Kakari S., Papavassiliou K. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy. Anticancer Res 1992; 12(1)251–256
   PubMed Web of Science ®Google Scholar
• Patel P. S., Raval G. N., Rawal R. M., Patel G. H., Balar D. B., Shah P. M., Patel D. D. Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer. Neoplasma 1995; 42(15)271–274
   PubMedGoogle Scholar
• Moll R., Franke W. W., Schiller D. L., Geiger B., Krepler R. The catalog of human cytokeratins: patterns of expression in normal ephitelia, tumors and cultured cells. Cell 1982; 31(1)11–24
   PubMed Web of Science ®Google Scholar
• Buccheri G., Ferrigno D. Cytokeratin-derived markers of lung cancer. Expert Rev Mol Diagn 2001; 1(3)315–322
   PubMedGoogle Scholar
• Chen M., Hofestadt R. A medical bioinformatics approach for metabolics disorders. Biomedical data prediction, modelling, and systematic analysis. J Biomed Inform 2006; 39(2)147–159
   PubMed Web of Science ®Google Scholar
• Mosconi C., Agradi E., Gambetta A., Bozzetti F., Galli C. Decrease of polyunsaturated fatty acids and elevation of the oleic/stearic acid ratio in plasma and red blood cell lipids of malnourished cancer patients. JPEN J Parenter Enteral Nutr 1989; 13(5)501–504
   PubMed Web of Science ®Google Scholar
• Newcomer L. M., King I. B., Wicklund K. G., Stanford J. L. The association of fatty acids with prostate cancer risk. Prostate 2001; 47(4)262–268
   PubMed Web of Science ®Google Scholar
• Pala V., Krogh V., Muti P., Chajes V., Riboli E., Micheli A., Saadatian M., Sieri S., Berrino F. Erythrocyte membrane fatty acids and subsequent breast cancer: a prospective Italian study. J Natl Cancer Inst 2001; 93(14)1088–1095
   PubMed Web of Science ®Google Scholar
• Mikirova N., Riordan H. D., Jackson J. A., Wong K., Miranda-Massari J. R., Gonzalez M. J. Erythrocyte membrane fatty acid composition in cancer patients. P R Health Sci J 2004; 23(2)107–113
   PubMedGoogle Scholar
• Yi L. Z., He J., Liang Y. Z., Yuan D. L., Chau F. T. Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GC/MS and PLS-LDA. FEBS Lett 2006; 580(30)6837–6845
   PubMed Web of Science ®Google Scholar
• de Castro J., Hernández-Hernández A., Rodríguez M. C., Llanillo M., Sánchez-Yagüe J. Comparison of changes in erythrocyte and platelet fatty acid composition and protein oxidation in advanzed non-small cell lung cancer. Cancer Invest 2006; 24(4)339–345
   PubMed Web of Science ®Google Scholar
• Zieba M., Suwalski M., Kwiatkowska S., Piasecka G., Grzelewska-Rzymowska I., Stolarek R., Nowak D. Comparison of hydrogen peroxide generation and the content of lipid peroxidation products in lung cancer tissue and pulmonary parenchyma. Respir Med 2000; 94(8)800–805
   PubMed Web of Science ®Google Scholar
• Kinnula V. L., Paakko P., Soini Y. Antioxidant enzymes and redox-regulating thiol proteins in malignancies of human lung. FEBS Lett 2004; 569(1–3)1–6
   PubMed Web of Science ®Google Scholar
• Hernandez-Hernandez A., Llanillo M., Rodriguez M. C., Gomez F., Sanchez-Yague J. Amphiphilic and hydrophilic nature of sheep and human platelet phosphotyrosine phosphatase forms. Biochim. Biophys Acta 1999; 1419(2)195–206
   PubMed Web of Science ®Google Scholar
• Hernandez-Hernandez A., Garabatos M. N., Rodríguez M. C., Vidal M. L., López-Revuelta A., Sánchez-Gallego J. I., Llanillo M., Sanchez-Yagüe J. Structural characteristics of a lipid peroxidation product, trans-2-nonenal, that favour inhibition of membrane-associated phosphotyrosine phosphatase activity. Biochim Biophys Acta 2005; 1726(3)317–325
   PubMed Web of Science ®Google Scholar
• Warren L. The thiobarbituric acid assay of sialic acids. J Biol Chem 1959; 234(8)1971–1975
   PubMed Web of Science ®Google Scholar
• Aminoff D. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J 1961; 81: 384–392, (Nov)
   PubMed Web of Science ®Google Scholar
• Gornall A. G., Bardawill C. J., David M. M. Determination of serum proteins by means of Biuret reaction. J Biol Chem 1949; 177(2)751–766
   PubMed Web of Science ®Google Scholar
• López-Revuelta A., Sánchez-Gallego J. I., Hernández-Hernández A., Sánchez-Yagüe J., Llanillo M. Membrane cholesterol contents influence the protective effects of quercetin and rutin in erythrocytes damaged by oxidative stress. Chem Biol Interact 2006; 161(1)79–91
   PubMed Web of Science ®Google Scholar
• López-Revuelta A., Sánchez-Gallego J. I., Hernández-Hernández A., Sánchez-Yagüe J., Llanillo M. Increase in vulnerability to oxidative damage in cholesterol-modified erythrocytes exposed to t-BuOOH. Biochim Biophys Acta 2005; 1734(1)74–85
   PubMed Web of Science ®Google Scholar
• de Castro J., Hernández-Hernández A., Rodríguez M. C., Sardina J. L., Llanillo M., Sánchez-Yagüe J. Comparison of changes in erythrocyte and platelet phospholipid and fatty acid composition and protein oxidation in chronic obstructive pulmonary disease and asthma. Platelets 2007; 18(1)43–51
   PubMed Web of Science ®Google Scholar
• Kaplan K. L., Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57(2)199–202
   PubMed Web of Science ®Google Scholar
• Buccheri G., Ferrigno D. Lung tumor markers of cytokeratin origin: an overview. Lung Cancer 2001; 34(Suppl. 2)S65–S69
   PubMedGoogle Scholar
• Fischer J. R., Lahm H. Validation of molecular and immunological factors with predictive importance in lung cancer. Lung Cancer 2004; 45(Suppl. 2)S151–S161
   PubMedGoogle Scholar
• Plabani M., Basso D., Navaglia F., De Paoli M., Tommasini A., Cipriani A. Clinical evaluation of seven tumor markers in lung cancer diagnosis: can any combination improbe the results?. Br J Cancer 1995; 72(1)170–173
   PubMed Web of Science ®Google Scholar
• Pujol J. L., Grenier J., Parrat E., Lehmann M., Lafontaine T., Quantin X., Michel F. B. Cytoqueratins as serum markers in lung cancer: a comparison of Cyfra 21-1 and TPS. Am J Respir Crit Care Med 1996; 154: 725–733, (3 Pt1)
   PubMed Web of Science ®Google Scholar
• Alatas F., Alatas Ö., Metintas M., Colak Ö., Harmanci E., Demir S. Diagnostic value of CEA, CA 15-3, CA 19-9, Cygra 21-1, NSE and TSA assay in pleural effusions. Lung Cancer 2001; 31(1)9–16
   PubMed Web of Science ®Google Scholar
• Kakari S., Stringou E., Toumbis M., Ferderigos A. S., Poulaki I., Chondros K., Dema A., Kotsovoulou V., Pavlidis N. Five tumor markers in lung cancer:significance of total and “lipid”-bound sialic acid. Anticancer Res 1991; 11(6)2107–2110
   PubMed Web of Science ®Google Scholar
• Plucinsky M. C., Riley W. M., Prorok J. J., Alhadeff J. A. Total and lipid associated serum sialic acid levels in cancer patients with different primary sites and different degree of metastatic involvement. Cancer 1986; 58(12)2680–2685
   PubMed Web of Science ®Google Scholar
• Feijoo-Carnero C., Rodríguez-Berrocal F. J., Páez de la Cadena M., Ayude D., de Carlos A., Martínez-Zorzano V. S. Clinical significance of preoperative serum sialic acid levels in colorectal cancer: utility in the detection of patients at high risk of tumor recurrence. Int J Biological Markers 2004; 19(1)38–45
   PubMed Web of Science ®Google Scholar
• Straface E., Masella R., Del Principe D., Franceschi C., Korkina L. G., Zatterale A., Pagano G., Malorni W. Spectrin changes occur in erythrocytes from patients with Fanconi's anemia and their parents. Biochem Biophys Res Commun 2000; 273(3)899–901
   PubMed Web of Science ®Google Scholar
• Straface E., Matarrese P., Gambardella L., Forte S., Carlone S., Libianchi E., Schmid G., Malorni W. N-acetylcisteine counteracts erythrocyte alterations occurring in chronic obstructive pulmonary disease. Biochem Biophys Res Commun 2000; 279(2)552–556
   PubMed Web of Science ®Google Scholar
• Straface E., Rivabene R., Masella R., Santulli M., Paganelli R., Malorni W. Structural changes of the erythrocyte as a marker of non-insulin-dependent diabetes. Protective effects of N-acetylcysteine. Biochem Biophys Res Commun 2002; 290(5)1393–1398
   PubMed Web of Science ®Google Scholar
• Hernández-Hernández A., Rodríguez M. C., López-Revuelta A., Sánchez-Gallego J. I., Shnyrov V., Llanillo M., Sánchez-Yagüe J. Alterations in erythrocyte membrane protein composition in advanced non-small cell lung cancer. Blood Cell Mol Dis 2006; 36(3)355–363
   PubMed Web of Science ®Google Scholar
• Khyshiktuev B. S., Khyshiktueva N. A., Ivanov V. N., Darenskaia S. D., Novikov S. V. Fatty acid composition of blood plasma lipids and erythrocytes in lung cancer patients. Vopr Med Khim 1994; 40(5)48–50
   PubMedGoogle Scholar
• Prisco D., Paniccia R., Coppo M., Filippini M., Francalanci I., Brunelli T., Comeglio P., Abbate R. Platelet activation and platelet lipid composition in pulmonary cancer. Prostaglandins Leukot Essent Fatty Acids 1995; 53(1)65–68
   PubMed Web of Science ®Google Scholar
• Prisco D., Rogasi P. G., Paniccia R., Abbate R., Gensini G. F., Pinto S., Vanni D, Neri-Serneri G. G. Altered membrane fatty acid composition and increased thromboxane A2 generation in platelets from patients with diabetes. Prostaglandins Leukot Essent Fatty Acids 1989; 35(1)15–23
   PubMed Web of Science ®Google Scholar
• Nakamura M. T., Nara T. Y. Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu Rev Nutr 2004; 24: 345–376
   PubMed Web of Science ®Google Scholar
• Kinnula V. L., Paakko P., Soini Y. Antioxidant enzymes and redox-regulating thiol proteins in malignancies of human lung. FEBS Lett 2004; 569(1–3)1–6
   PubMed Web of Science ®Google Scholar